Figures & data
Figure 1 The expression of miR-300 in OSCC tissues and cells.
Abbreviation: OSCC, oral squamous cell carcinoma.
![Figure 1 The expression of miR-300 in OSCC tissues and cells.](/cms/asset/6410ddb3-c6d9-47c8-b613-9f133e4fd07d/dott_a_173236_f0001_b.jpg)
Table 1 The relationship between miR-300 and the clinicopathologic characteristics in OSCC patients
Table 2 Univariate and multivariate Cox proportional hazards model for OS and DFS in OSCC patients
Figure 2 The prognostic value of miR-300 in OSCC.
Abbreviation: OSCC, oral squamous cell carcinoma.
![Figure 2 The prognostic value of miR-300 in OSCC.](/cms/asset/5e19e06b-dd81-4e87-a0e6-4773ae50f490/dott_a_173236_f0002_c.jpg)
Figure 3 miR-300 inhibits the proliferation and invasion abilities.
Abbreviations: PCR, polymerase chain reaction; NC, negative control.
![Figure 3 miR-300 inhibits the proliferation and invasion abilities.](/cms/asset/99362997-4a7d-44d4-93a6-98b85ef66f02/dott_a_173236_f0003_c.jpg)
Figure 4 miR-300 inhibits the EMT of OSCC cells.
Abbreviations: EMT, epithelial–mesenchymal transition; OSCC, oral squamous cell carcinoma; NC, negative control.
![Figure 4 miR-300 inhibits the EMT of OSCC cells.](/cms/asset/9ace2b64-9b40-4bbb-a1cd-ca22f8e1532f/dott_a_173236_f0004_b.jpg)
![Figure 4 miR-300 inhibits the EMT of OSCC cells.](/cms/asset/1a0621e6-49e7-4cce-8d85-17972beef860/dott_a_173236_f0004a_b.jpg)
Figure 5 ET-1 promotes cell migration and EMT expression by downregulating miR-300 expression in OSCC cells.
Abbreviations: EMT, epithelial–mesenchymal transition; ET-1, endothelin-1; OSCC, oral squamous cell carcinoma; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.
![Figure 5 ET-1 promotes cell migration and EMT expression by downregulating miR-300 expression in OSCC cells.](/cms/asset/b6e46de6-dfc8-4b79-b973-16c331905df9/dott_a_173236_f0005_b.jpg)